VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 38 filers reported holding VERA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,584,887 | -6.6% | 1,574,390 | +9.3% | 0.00% | 0.0% |
| Q2 2023 | $23,116,253 | +113.6% | 1,440,265 | +3.3% | 0.00% | – |
| Q1 2023 | $10,824,044 | -27.1% | 1,394,851 | +81.7% | 0.00% | – |
| Q4 2022 | $14,851,764 | -8.2% | 767,533 | +1.1% | 0.00% | – |
| Q3 2022 | $16,171,000 | +75.5% | 758,832 | +12.1% | 0.00% | – |
| Q2 2022 | $9,214,000 | -36.5% | 676,937 | +9.5% | 0.00% | – |
| Q1 2022 | $14,517,000 | +39.7% | 618,003 | +58.9% | 0.00% | – |
| Q4 2021 | $10,394,000 | +143.7% | 388,978 | +58.2% | 0.00% | – |
| Q3 2021 | $4,265,000 | +515.4% | 245,835 | +370.3% | 0.00% | – |
| Q2 2021 | $693,000 | – | 52,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $57,280,470 | 18.66% |
| Kynam Capital Management, LP | 1,409,098 | $27,266,046 | 4.18% |
| Sofinnova Investments, Inc. | 3,181,442 | $61,560,903 | 3.65% |
| Octagon Capital Advisors LP | 665,156 | $12,870,769 | 2.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,257 | $5,428,260 | 1.68% |
| Vivo Capital, LLC | 400,666 | $7,753 | 0.89% |
| Eversept Partners, LP | 411,308 | $7,958,810 | 0.70% |
| Logos Global Management LP | 285,000 | $5,514,750 | 0.65% |
| Alphabet Inc. | 301,580 | $5,835,573 | 0.34% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $310,761 | 0.17% |